Helsingborg, Sweden

Bertil Hogberg

This inventor holds 7 USPTO granted patents. Top assignee: Aktiebolaget Leo. Active years: 1976-1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bertil Hogberg. Retrieved from https://idiyas.com/inventor/bertil-hogberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Helsingsborg, SE (1976)
  • Helsingborg, SE (1976 - 1979)

Company Filing History:


Years Active: 1976-1979

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Inventor Spotlight: Bertil Hogberg

Introduction:

Bertil Hogberg, a renowned inventor hailing from Helsingborg, Sweden, has made significant contributions to the field of pharmacology through his innovative patents.

Latest Patents:

Hogberg's latest patents include groundbreaking inventions such as novel secondary phosphoric acid esters and salts with valuable pharmacological properties. These compounds serve as selective inhibitors of prostaglandins and Slow Reacting Substances (SRS), inhibiting the formation of cyclic AMP and exerting intrinsic smooth muscle stimulatory activity. Pharmaceutical compositions containing these compounds offer novel methods of treatment.

Career Highlights:

Bertil Hogberg is a key figure at Aktiebolaget Leo, where his inventive spirit and dedication to pharmacology have propelled him to the forefront of the industry. With a total of 5 patents to his name, Hogberg continues to push the boundaries of innovation in drug development.

Collaborations:

Throughout his career, Hogberg has collaborated closely with esteemed coworkers such as Hans Jacob Fex and Torsten Rune Perklev. Together, they have combined their expertise to achieve remarkable milestones in the field of pharmacology.

Conclusion:

In conclusion, Bertil Hogberg stands as a pioneering inventor whose patents have revolutionized the pharmaceutical landscape. His relentless pursuit of innovation and collaboration with industry experts have solidified his position as a leader in pharmacological research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…